Horizon Kinetics Medical ETF
MEDX
7 hedge funds and large institutions have $432K invested in Horizon Kinetics Medical ETF in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
506% more capital invested
Capital invested by funds: $71.3K → $432K (+$360K)
75% more funds holding
Funds holding: 4 → 7 (+3)
3.05% more ownership
Funds ownership: 0.54% → 3.59% (+3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$379K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$28.8K |
| 3 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$86 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$29 |
Top Sellers
MEDX Hedge Fund Activity: Q4 2024 in Review
7 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Horizon Kinetics Medical ETF (MEDX) for Q4 2024, worth a combined $432K — up 506% from $71.3K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MEDX positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $379K.
- 7 institutional investors held Horizon Kinetics Medical ETF (MEDX) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $432K of Horizon Kinetics Medical ETF stock for Q4 2024, up 506% quarter-over-quarter.
- 3 funds opened new Horizon Kinetics Medical ETF positions in Q4 2024 and 0 closed out, a net change of +3 holders.
- The largest Horizon Kinetics Medical ETF buyer in Q4 2024 was Citadel Advisors, an estimated $379K added.
Based on aggregated 13F filings for Q4 2024.